US vaccine firm: Human trials could be held in Israel as infection rates rise

News

Jul 27, 2020 | News | Jerusalem & Area
US vaccine firm: Human trials could be held in Israel as infection rates rise

The head of a US firm developing a COVID-19 vaccine said Sunday that as infection rates of the coronavirus rise in Israel, it could be used as a location for human trials.

“My understanding is that Israel is under some significant challenges with respect to the prevalence of COVID, and it would present an opportunity to perhaps do the registration study in Israel, combining that data with other countries as well,” Arcturus Therapeutics CEO Joseph Payne told Channel 12 news, referring to the Phase 3 human trials.

Full Story (The Times of Israel)


Share: